The Prescription Drug Pricing Act, penned by Senator Charles Grassley, R-Iowa, and co-sponsored by Senator Ron Wyden, D-Oregon, is in a odd condition of limbo, sitting down on the Senate’s legislative calendar for months. But if and when it ever passes, it could stand to help save billions.
Based on estimates from the Congressional Budget Office, the invoice could help save much more than $ninety four billion in excess of the up coming ten several years, owing in section to demanding cost reporting controls on pharmaceutical organizations and the continuance of drug manufacturer rebates.
At question is what will eventually come about to the invoice. While it passed through the Senate Finance Committee, no vote has nevertheless been taken, and at this place it can be unclear if and when it will.
What’s THE Impact
The bill’s principal provision would restrict drug cost improves in Medicare Aspect D. Pharmaceutical prices